Meirong Bai

Meirong Bai is a scientist with extensive experience in molecular biology and a focus on ischemia-reperfusion injury mechanisms. Currently employed at Synthego Corporation since October 2022, Meirong previously worked at Alamar Biosciences, Inc. as a scientist from February 2022 to October 2022. Meirong served as a postdoctoral fellow at UCSF from January 2019 to January 2021 and as a postdoctoral scholar at the University of California, San Francisco, from February 2015 to December 2018. Meirong holds a Doctor of Philosophy (Ph.D.) in Molecular Biology from Fudan University and a Bachelor's degree in Biology from East China Normal University.